AUG 05, 2020 2:23 PM PDT

Age-old Immune Components Affecting COVID-19 Severity

WRITTEN BY: Kara Marker

One of the most unsettling aspects of the coronavirus pandemic is the wide range of severity those affected seem to experience. A new study may offer new insight into what makes some cases progress to the more severe end of the spectrum.

Researchers discovered that the immune system’s complement system may affect how severely a case of COVID-19 progresses. Various diseases and disorders are associated with complement, and thus associated with higher risk for severe COVID-19 complications and COVID-19-related death:

  • Age-related macular degeneration (AMD)
  • Clotting activity
  • Coagulation disorders, like thrombosis and hemorrhage
  • Obesity and diabetes

What is Complement?

Complement was discovered at the very end of the 19th century in blood plasma and immediately associated with the immune system’s ability to flag and destroy potential pathogens. More than 20 proteins make up multiple pathways of the complement system that activate sequentially if triggered by the presence of certain microorganisms.

But, immune function is known for occasionally going awry, leading to inflammatory disorders and autoimmune disease like rheumatoid arthritis or seasonal allergies. The complement system’s overactivity in cases of severe COVID-19 may be just another, more severe consequence of immune function gone awry.

Studying “Viral Mimicry”

Researchers began by observing that coronaviruses, like the one that caused COVID-19, are “masters of mimicry,” meaning that their viral proteins may mimic host proteins to encourage host cells into helping the virus complete its life cycle during infection. In the case of COVID-19, this means that affected proteins include coagulation and complement proteins.

Next, researchers analyzed data from more 11,000 COVID-19 patients from the Columbia University Irving Medical Center. More than 25 percent of patients with AMD – which is caused by overactive complement - died, and about 20 percent with AMD required intubation. Both instances could not be explained by other factors. Researchers saw that people with a history of coagulation disorders were also more likely to die from COVID-19.

Lastly, researchers discovered a genetic signature in COVID-19 patients that essentially caught coronavirus “red-handed,” strongly activating both complement and coagulation. Similar findings came from genetic analyses of thousands of COVID-19 patients from the U.K. Biobank.

"As part of the immune system, you would expect to see complement activated, but it seems over and above what you'd see in other infections like the flu,” explained study co-leader Nichola Tatonetti, PhD.

The new study represents a new important opportunity to utilize drugs for COVID-19 that already exist to inhibit complement.

Sources: British Society for Immunology, European Journal of Microbiology & Immunology, Columbia University Irving Medical Center, Nature Medicine

 

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 09, 2020
Microbiology
Fighting COVID-19 with Help From Llamas
NOV 09, 2020
Fighting COVID-19 with Help From Llamas
Camelids, which include llamas, alpacas and camels have immune systems that generate two kinds of antibodies when confro ...
NOV 16, 2020
Genetics & Genomics
Hidden Genes in the SARS-CoV-2 Genome
NOV 16, 2020
Hidden Genes in the SARS-CoV-2 Genome
It's essential for organisms to use their genomes to make proteins, and the processes of transcription and translation a ...
DEC 18, 2020
Chemistry & Physics
New research on the physical dynamics of SARS-CoV-2 on surfaces
DEC 18, 2020
New research on the physical dynamics of SARS-CoV-2 on surfaces
New research published in Advanced Nano-Biomed Research contemplates the physical dynamics of SARS-CoV-2 on abiotic ...
JAN 24, 2021
Microbiology
Cholesterol Enables SARS-CoV-2 to Invade & Create 'Mega-Cells'
JAN 24, 2021
Cholesterol Enables SARS-CoV-2 to Invade & Create 'Mega-Cells'
To cause the COVID-19 illness, the SARS-CoV-2 virus first has to get into cells. To do so, it uses something called a sp ...
MAR 16, 2021
Immunology
What Happens When Your Immune System Forgets
MAR 16, 2021
What Happens When Your Immune System Forgets
One of the most remarkable features of the immune system is its ability to “remember” past encounters with p ...
APR 02, 2021
Drug Discovery & Development
Anti-Parasitic Medication Could Be Therapy for COVID19
APR 02, 2021
Anti-Parasitic Medication Could Be Therapy for COVID19
What are tropical and neglected diseases? Chronic infections that plague developing nations with often little financial ...
Loading Comments...